Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Cooperative Targeting of Bcl-2 Family Proteins By ABT-199 (GDC-0199) and Tyrosine Kinase Inhibitors to Eradicate Blast Crisis CML and CML Stem/Progenitor Cells

Bing Z Carter, PhD, Po Yee Mak, Hong Mu, MD PhD, Hongsheng Zhou, Duncan H Mak, M.S., Wendy D. Schober, MLT (ASCP), Joel Leverson, PhD, Bin Zhang, PhD, Ravi Bhatia, MD, Marina Konopleva, MD PhD, Jorge E. Cortes, Michael Andreeff, MD PhD

Blood (2014) 124 (21): 512.

https://doi.org/10.1182/blood.V124.21.512.512

Published: 2014

Journal Articles

Ablation of Autophagy-Related E1 Ligase Atg7 Primes Acute Myelogenous Leukemia Cells to Apoptosis, Sensitizes to Chemotherapy and Overcomes Stroma Mediated Protection

Sujan Piya, PhD, Vivian R Ruvolo, MA, Peter P. Ruvolo, PhD, Richard E. Davis, MD, Zhiqiang Wang, Teresa McQueen, BS, Wendy D Schober, PhD, Michael Andreeff, MD PhD, Gautam Borthakur, MD

Blood (2014) 124 (21): 901.

https://doi.org/10.1182/blood.V124.21.901.901

Published: 2014

Journal Articles

GCS-100 Induces Apoptosis of Acute Myeloid Leukemia Cells By Disrupting Galectin-Mediated Survival Signaling

Richard E. Davis, MD, Vivian R Ruvolo, MA, Zhiqiang Wang, Wencai Ma, PhD, Wendy D. Schober, MLT (ASCP), James Rolke, George Tidmarsh, MD PhD, Michael Andreeff, MD PhD, Peter P. Ruvolo, PhD

Blood (2014) 124 (21): 904.

https://doi.org/10.1182/blood.V124.21.904.904

Published: 2014

Journal Articles

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance

Blood (2014) 123 (17): 2691–2702.

https://doi.org/10.1182/blood-2013-06-511527

Published: 2014

Includes: Supplemental data

Journal Articles

Cord Blood CD34 + Stem Cell Sialyl Lewis X Levels and E-Selectin Binding Are Predictive Of Engraftment In Mice: Functional Separation Of Stemness and Homing To Improve Engraftment

Patrick A Zweidler-McKay, MD, PhD, Simon N Robinson, PhD, Michael W Thomas, PhD, JunJun Lu, PhD, Hong Yang, PhD, Richard E Champlin, MD, Wendy D Schober, PhD, Paul J Simmons, PhD, Elizabeth J Shpall, MD

Blood (2013) 122 (21): 893.

https://doi.org/10.1182/blood.V122.21.893.893

Published: 2013

Journal Articles

NF-κB Activation in Mesenchymal Stromal Cells Mediates Leukemia Cell Chemoresistance

Rodrigo Jacamo, Ph.D, Ye Chen, PhD, Zhiqiang Wang, Ph.D., Wencai Ma, Ph.D., Min Zhang, Ph.D., Venkata L Battula, Ph.D., Wendy D. Schober, MLT (ASCP), Richard E Davis, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD

Blood (2012) 120 (21): 3518.

https://doi.org/10.1182/blood.V120.21.3518.3518

Published: 2012

Journal Articles

Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse

Blood (2012) 120 (21): 360.

https://doi.org/10.1182/blood.V120.21.360.360

Published: 2012

Journal Articles

Proteomic Profiling of AML Bone Marrow-Derived Mesenchymal Stem Cells (MSC) Reveals Marked Differences From Normal MSC.

Rui-yu Wang, MD, PhD, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Teresa McQueen, BS, Ye Chen, PhD, Zhihong Zeng, MD, Kevin R. Coombes, PhD, Wendy D. Schober, MLT (ASCP), Marina Konopleva, MD, PhD, Steven M. Kornblau, MD, PhD, Michael Andreeff, MD, PhD

Blood (2012) 120 (21): 2355.

https://doi.org/10.1182/blood.V120.21.2355.2355

Published: 2012

Journal Articles

Targeting XIAP and ARC (apoptosis repressor with caspase recruitment domain) Overcomes Imatinib Resitance In Blast Crisis CML Cells.

Bing Carter, Ph.D., Duncan H. Mak, M.S., Wendy D. Schober, Marina Konopleva, MD, PhD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Erich Koller, Ziwei Huang, John C. Reed, MD, PhD, Michael Andreeff, M.D., Ph.D.

Blood (2010) 116 (21): 3415.

https://doi.org/10.1182/blood.V116.21.3415.3415

Published: 2010

Journal Articles

The Synergistic Effect of DNA Methylation Inhibitor 5-Azacytidine and Bcl-2 Signaling Blockade ABT-737 Combination Treatment Induce Apoptosis In AML

Yuexi Shi, Twee Tsao, Hongbo Lu, MMSC, Sergej Konoplev, MD, PhD, Wendy D. Schober, Michael Andreeff, MD, PhD, Marina Konopleva, MD, PhD

Blood (2010) 116 (21): 3311.

https://doi.org/10.1182/blood.V116.21.3311.3311

Published: 2010

Journal Articles

A Phase I/II Trial of Plerixafor/G-CSF Combined with IV Bu/Flu Conditioning Regimen In AML/MDS Patients Undergoing Allogenic Stem Cell Transplantation

Blood (2010) 116 (21): 2358.

https://doi.org/10.1182/blood.V116.21.2358.2358

Published: 2010

Journal Articles

Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML

Bing Z. Carter, Duncan H. Mak, Wendy D. Schober, Erich Koller, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

Blood (2010) 115 (2): 306–314.

https://doi.org/10.1182/blood-2009-03-212563

Published: 2010

Includes: Supplemental data

Journal Articles

Mesenchymal Stem Cells From Patients with Acute Myeloid Leukemia (AML) Can Differentiate Into B-Cells in NOD/SCID/IL-2Rγ -/- Mice .

Rui-Yu Wang, MD, PhD, Yue-Xi Shi, Zhihong Zeng, MD, Wendy D. Schober, Teresa J. McQueen, BS, Vicki L. Hopwood, MS, BS, Borys Korchin, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD

Blood (2009) 114 (22): 4573.

https://doi.org/10.1182/blood.V114.22.4573.4573

Published: 2009

Journal Articles

Inhibition of Bcl-2/Bcl-X L Promotes Apoptosis in Blast Crisis CML Including Quiescent Primitive Progenitor Cells Regardless of Cellular Responses to Tyrosine Kinase Inhibitors.

Duncan H. Mak, Wendy D. Schober, Marina Konopleva, MD, PhD, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Michael Andreeff, MD, PhD, Bing Z. Carter, PhD

Blood (2009) 114 (22): 646.

https://doi.org/10.1182/blood.V114.22.646.646

Published: 2009

Journal Articles

Simultaneous Activation of p53 and Inhibition of XIAP Enhance the Activation of Apoptosis Signaling Pathways in AML.

Bing Z. Carter, PhD, Duncan H. Mak, Wendy D. Schober, Erich Koller, PhD, Clemencia Pinilla, PhD, Lyubomir T. Vassilev, PhD, John C. Reed, MD, PhD, Michael Andreeff, MD, PhD

Blood (2008) 112 (11): 1941.

https://doi.org/10.1182/blood.V112.11.1941.1941

Published: 2008

Journal Articles

Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5

Bing Z. Carter, Duncan H. Mak, Wendy D. Schober, Martin F. Dietrich, Clemencia Pinilla, Lyubomir T. Vassilev, John C. Reed, Michael Andreeff

Blood (2008) 111 (7): 3742–3750.

https://doi.org/10.1182/blood-2007-05-091504

Published: 2008

Journal Articles

Inhibition of KSP by ARRY-520 Induces Cell Cycle Block and Cell Death Via the Mitochondrial Pathway in AML Cells.

Bing Z. Carter, PhD, Duncan H. Mak, MS, Wendy D. Schober, BS, Richard Woessner, PhD, Stefan Gross, PhD, David Harris, BS, Zeev Estrov, MD, Michael Andreeff, MD, PhD

Blood (2007) 110 (11): 2782.

https://doi.org/10.1182/blood.V110.11.2782.2782

Published: 2007

Journal Articles

Apoptosis Inducing Factor Acts as a Survival Factor in Acute Myelogenous Leukemia through Mitochondrial Complex 1.

Rui-yu Wang, MD, PhD, Ismael J. Samudio, PhD, Teresa McQueen, BS, Wendy D. Schober, MLT, Vivian R. Ruvolo, Steven Kornblau, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD

Blood (2007) 110 (11): 1812.

https://doi.org/10.1182/blood.V110.11.1812.1812

Published: 2007

Journal Articles

Triptolide Induces Cell Death Independent of Cellular Responses to Imatinib in Blast Crisis CML Cells and Sensitizes Imatinib.

Duncan H. Mak, MS, Wendy D. Schober, BS, Wenjing Chen, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Michael Andreeff, MD, PhD., Bing Z. Carter, PhD

Blood (2007) 110 (11): 1610.

https://doi.org/10.1182/blood.V110.11.1610.1610

Published: 2007

Journal Articles

MEK Inhibitor AZD6244 Induces Cell Growth Arrest and Synergizes Nutlin-3a-Mediated Cell Death by Upregulating p53 and PUMA Levels in Acute Myelogenous Leukemia.

Weiguo Zhang, MD, PhD, Marina Konopleva, MD, PhD, Wendy D. Schober, MLT, Teresa McQueen, BS, Michael Andreeff, MD, PhD

Blood (2007) 110 (11): 654.

https://doi.org/10.1182/blood.V110.11.654.654

Published: 2007

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Cooperative Targeting of Bcl-2 Family Proteins By ABT-199 (GDC-0199) and Tyrosine Kinase Inhibitors to Eradicate Blast Crisis CML and CML Stem/Progenitor Cells

Ablation of Autophagy-Related E1 Ligase Atg7 Primes Acute Myelogenous Leukemia Cells to Apoptosis, Sensitizes to Chemotherapy and Overcomes Stroma Mediated Protection

GCS-100 Induces Apoptosis of Acute Myeloid Leukemia Cells By Disrupting Galectin-Mediated Survival Signaling

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance

Cord Blood CD34 + Stem Cell Sialyl Lewis X Levels and E-Selectin Binding Are Predictive Of Engraftment In Mice: Functional Separation Of Stemness and Homing To Improve Engraftment

NF-κB Activation in Mesenchymal Stromal Cells Mediates Leukemia Cell Chemoresistance

Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse

Proteomic Profiling of AML Bone Marrow-Derived Mesenchymal Stem Cells (MSC) Reveals Marked Differences From Normal MSC.

Targeting XIAP and ARC (apoptosis repressor with caspase recruitment domain) Overcomes Imatinib Resitance In Blast Crisis CML Cells.

The Synergistic Effect of DNA Methylation Inhibitor 5-Azacytidine and Bcl-2 Signaling Blockade ABT-737 Combination Treatment Induce Apoptosis In AML

A Phase I/II Trial of Plerixafor/G-CSF Combined with IV Bu/Flu Conditioning Regimen In AML/MDS Patients Undergoing Allogenic Stem Cell Transplantation

Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML

Mesenchymal Stem Cells From Patients with Acute Myeloid Leukemia (AML) Can Differentiate Into B-Cells in NOD/SCID/IL-2Rγ -/- Mice .

Inhibition of Bcl-2/Bcl-X L Promotes Apoptosis in Blast Crisis CML Including Quiescent Primitive Progenitor Cells Regardless of Cellular Responses to Tyrosine Kinase Inhibitors.

Simultaneous Activation of p53 and Inhibition of XIAP Enhance the Activation of Apoptosis Signaling Pathways in AML.

Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5

Inhibition of KSP by ARRY-520 Induces Cell Cycle Block and Cell Death Via the Mitochondrial Pathway in AML Cells.

Apoptosis Inducing Factor Acts as a Survival Factor in Acute Myelogenous Leukemia through Mitochondrial Complex 1.

Triptolide Induces Cell Death Independent of Cellular Responses to Imatinib in Blast Crisis CML Cells and Sensitizes Imatinib.

MEK Inhibitor AZD6244 Induces Cell Growth Arrest and Synergizes Nutlin-3a-Mediated Cell Death by Upregulating p53 and PUMA Levels in Acute Myelogenous Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only